Literature DB >> 27038335

Risk of self-harm and nonfatal suicide attempts, and completed suicide in patients with psoriasis: a population-based cohort study.

A Egeberg1,2, P R Hansen3, G H Gislason3,4,5, L Skov6, L Mallbris7.   

Abstract

BACKGROUND: Psoriasis is a common inflammatory skin disease, and inflammation may affect suicidal behaviour. Current data on the incidence and risk of suicidal behaviour in patients with psoriasis are scarce.
OBJECTIVES: We investigated the association between psoriasis and the risk of self-harm and suicide attempts and suicides.
METHODS: All Danish patients aged ≥ 18 years with mild or severe psoriasis (cases) from 1 January 1997 to 31 December 2011 were matched on age, sex and calendar time 1 : 5 with healthy controls. The outcome was a diagnosis of self-harm or a nonfatal suicide attempt, or completed suicide. Incidence rates per 10 000 person-years were calculated, and incidence rate ratios (IRRs) and confidence intervals (CIs) were estimated by Poisson regression models.
RESULTS: The study cohort comprised 408 663 individuals, including 57 502 and 11 009 patients with mild and severe psoriasis, respectively. In total 280 cases of self-harm or suicide attempts, and 574 suicides occurred during follow-up. There was no increased risk of self-harm or suicide attempts in patients with mild psoriasis (IRR 1·01, 95% CI 0·17-2·01), but this risk was significantly increased in severe psoriasis (IRR 1·69, 95% CI 1·00-2·84). There was no increased risk of suicides in mild (IRR 1·05, 95% CI 0·84-1·32) or severe psoriasis (IRR 0·78, 95% CI 0·45-1·36). Similar results were found when suicides were confirmed by official forensic investigations, and when psoriasis was compared with atopic dermatitis.
CONCLUSIONS: We found limited evidence to suggest an increased risk of self-harm and nonfatal suicide attempts in patients with psoriasis. Importantly, after adjustment for psoriatic arthritis this risk was no longer significantly increased. The risk of completed suicide was also not increased, regardless of psoriasis severity.
© 2016 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2016        PMID: 27038335     DOI: 10.1111/bjd.14633

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  12 in total

Review 1.  Neuropathology of suicide: recent findings and future directions.

Authors:  P-E Lutz; N Mechawar; G Turecki
Journal:  Mol Psychiatry       Date:  2017-07-11       Impact factor: 15.992

2.  Risk for incident suicidality among psoriasis patients: a systematic review and meta-analysis.

Authors:  Wei-Kai Hung; Tao-Hsin Tung; Tzu-Yu Wang; Shih-Cheng Liao; Ching-Chi Chi
Journal:  Arch Dermatol Res       Date:  2022-08-12       Impact factor: 3.033

3.  Predictors of Response to Biologics in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Cohort Study.

Authors:  Christopher Willy Schwarz; Nikolai Loft; Mads Kirchheiner Rasmussen; Christoffer V Nissen; Tomas Norman Dam; Kawa Khaled Ajgeiy; Alexander Egeberg; Lone Skov
Journal:  Acta Derm Venereol       Date:  2021-10-26       Impact factor: 3.875

4.  Eczema and subsequent suicide: a matched case-control study.

Authors:  Aaron Mark Drucker; Deva Thiruchelvam; Donald A Redelmeier
Journal:  BMJ Open       Date:  2018-11-25       Impact factor: 2.692

Review 5.  Comorbidities of Atopic Dermatitis: Beyond Rhinitis and Asthma.

Authors:  Yuki M F Andersen; Alexander Egeberg; Lone Skov; Jacob P Thyssen
Journal:  Curr Dermatol Rep       Date:  2017-01-21

Review 6.  The Pathophysiological Mechanisms and the Quest for Biomarkers in Psoriasis, a Stress-Related Skin Disease.

Authors:  Mircea Tampa; Maria-Isabela Sarbu; Madalina-Irina Mitran; Cristina-Iulia Mitran; Clara Matei; Simona-Roxana Georgescu
Journal:  Dis Markers       Date:  2018-01-28       Impact factor: 3.434

7.  The risk of deliberate self-harm following a diagnosis of rheumatoid arthritis or ankylosing spondylitis: A population-based cohort study.

Authors:  Bindee Kuriya; Simone Vigod; Jin Luo; Jessica Widdifield; Nigil Haroon
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

8.  Safety results of ixekizumab with 1822.2 patient-years of exposure: an integrated analysis of 3 clinical trials in adult patients with psoriatic arthritis.

Authors:  Bernard Combe; Proton Rahman; Hideto Kameda; Juan D Cañete; Gaia Gallo; Noah Agada; Wen Xu; Mark C Genovese
Journal:  Arthritis Res Ther       Date:  2020-01-21       Impact factor: 5.156

9.  Investigating evidence for a causal association between inflammation and self-harm: A multivariable Mendelian Randomisation study.

Authors:  Abigail Emma Russell; Tamsin Ford; David Gunnell; Jon Heron; Carol Joinson; Paul Moran; Caroline Relton; Matthew Suderman; Gibran Hemani; Becky Mars
Journal:  Brain Behav Immun       Date:  2020-05-28       Impact factor: 19.227

10.  What Factors Influence on Dermatology-Related Life Quality of Psoriasis Patients in South Korea?

Authors:  So Young Park; Kon Hee Kim
Journal:  Int J Environ Res Public Health       Date:  2021-03-31       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.